Cited by 72Thyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryThyroid Cancer Diagnosis and Treatment

Thyroxine replacement: a clinical endocrinologist’s viewpoint

Eligar, V, Taylor, PN, Okosieme, OE, Leese, GP, Dayan, CM·2016·Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Abstract

Background: Hypothyroidism affects 2–5% of the general population. Patients with uncorrected disease suffer significant morbidity and have an increased risk of cardiovascular disease and neurocognitive impairment. Levothyroxine, the treatment of choice, is inexpensive, easy to administer and in most cases restores well-being while normalizing thyroid function. However, 30–50% of individuals on levothyroxine are either over-treated or under-treated and others remain dissatisfied with treatment despite achieving thyroid hormone concentrations within the laboratory reference interval. Methods: This review is based on a systematic search of the literature for controlled trials, systematic reviews, guideline papers and cohort studies addressing best practice in thyroid hormone replacement. Results: Recent decades have seen improvements in patient management strategies driven by a better appreciation of levothyroxine pharmacokinetics. However, aspects of therapy such as the optimal timing of medication, strategies to overcome treatment non-adherence and target thyroid stimulating hormone concentrations in pregnancy and in patients with differentiated thyroid cancer remain challenging. Furthermore, there is now a substantial body of literature on common genetic variations in the deiodinases and thyroid hormone transporters and their role in the local regulation of thyroid hormone delivery. The benefits of combination therapy with liothyronine and levothyroxine are uncertain, and while it is theoretically probable that subsets of genetically predisposed individuals will benefit from combination therapy the existing evidence is as yet limited. Conclusion: Despite the availability of thyroid hormone replacement for more than a century, there are still substantial challenges in practice and opportunities to improve treatment outcomes.

Integrity signals

Registry

Crossref · 10.1177/0004563216642255

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Eligar, V, Taylor, P., Okosieme, O., Leese, G., & Dayan, C.
Affiliations
  • Cardiff University (GB)
  • Thyroid Research Group, Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Cardiff, UK
  • University of Dundee (GB)
Venue
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
Published
2016-04-28
Volume
53
Issue
4
Pages
421-433
ISSN
  • 0004-5632 (ISSN-L)
  • 1758-1001
OpenAlex
W2345078908
Cited by
72
References
118
Citations by year
2026: 5 · 2025: 9 · 2024: 9 · 2023: 13 · 2022: 9 · 2021: 11 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 2
FWCI
0.54
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Clinical Biochemistry International Journal of Laboratory Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
Funders
  • American Thyroid Association
  • Association for Clinical Biochemistry and Laboratory Medicine
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
levothyroxine, hypothyroidism, thyroid hormone replacement, medication adherence, pregnancy, differentiated thyroid cancer, thyroid hormone transporters, overtreatment and undertreatment
MeSH terms
Endocrinologists, Animals, Humans, Hypothyroidism, Thyrotropin, Thyroxine, Randomized Controlled Trials as Topic, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review